Verona pharma to present phase 2 data with pmdi ensifentrine in copd at chest 2021

Bronchodilation demonstrated with pmdi, consistent with dpi and nebulizer formulations bronchodilation demonstrated with pmdi, consistent with dpi and nebulizer formulations

VRNA Ratings Summary

VRNA Quant Ranking